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Volume 58, Number 2 Abstracts 561restored. Medical therapy will continue as long as there is observed clinical
beneﬁt. There were no apparent adverse side effects of sirolimus therapy.
Conclusions: While vascular malformations must be managed on an
individual basis, this case presents a potentially promising method to treat
those with severe complications. A staged surgical and medical approach
restored normal limb function and resolved critical consumptive coagulop-
athy in an infant. The optimal choice for medical therapy requires further
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Objectives: Studies have shown that individuals with a thin or
ruptured ﬁbrous cap on carotid magnetic resonance imaging (MRI) are at
greater risk for transient ischemic attack or stroke. Autopsy studies docu-
ment a similar relationship between cap rupture and myocardial infarction
(MI). Recent evidence suggests that a single nucleotide polymorphism in
the promoter region of the CDKN1B gene, a cell cycle regulator, is associ-
ated with a two-fold increased risk of MI. These studies indicate that the
-838A allele is associated with increased CDKN1B expression and decreased
proliferation of vascular smooth muscle cells (SMC). Reduction in SMC
proliferation may result in decrease in the thickness of the ﬁbrous cap,
setting the stage for cap rupture. The objective of this study is to test that
hypothesis that the -838A allele of the CDKN1B gene is associated with
the presence of a thin or ruptured ﬁbrous cap on carotid MRI.
Methods: 276 subjects with 16-79% carotid stenosis by ultrasound
were recruited for the study. Carotid MRI scans were performed on a 1.5 T
scanner (Signa Horizon EchoSpeed, GE Healthcare, Milwaukee, WI). The
index artery was analyzed by reviewers blinded to clinical and genetic informa-
tion. Carotid plaque composition and ﬁbrous cap status were recorded using
previously published criteria. The trend between number of A alleles and the
presence of a thin or ruptured ﬁbrous capwas assessed using logistic regression
under a codominant genetic model.
Results: Of the 276 carotid arteries, 42 (15%) were excluded due to
insufﬁcient image quality and 60 subjects did not agree to sample collection
for genotyping, leaving a total of 174 arteries for analysis. Sixty-one (35%) of
the plaques had a thin or ruptured cap. The Fig summarizes the prevalence
of thin/ruptured ﬁbrous cap by genotype. There was a trend toward
increasing prevalence of thin/ruptured caps with each A allele, but this
was of marginal statistical signiﬁcance (P ¼ .062) in this small sample.Fig.Conclusions: These preliminary data suggest a trend toward increasing
prevalence of thin/ruptured caps in carotid plaque associated with the
-838C>A polymorphism of the CDKN1B gene that warrants further study
in a larger cohort. Furthermore, this study demonstrates the utility of MRI
for examining the pathogenesis of the high-risk atherosclerotic plaque.
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Objectives: Screening for Abdominal Aortic Aneurysm (AAA)
reduces aneurysm related mortality. US Preventive Services Task Force
(USPTF) and American Heart Association (AHA) have recommended
screening in high risk groups since 2005. Since 2007, Medicare has covered
a one-time screening ultrasound for new male enrollees with a familial or
smoking history. Nevertheless, in the United States, screening has remained
underutilized. Review of patients with ruptured AAA in our system in 2009
showed the vast majority were undiagnosed yet met USPTF and AHA
screening guidelines. To reduce the number of preventable AAA ruptures
and deaths in our health plan members, we implemented an AAA screening
program using our electronic medical record (EMR). This study describes
the design, implementation and early results of that screening program.
Methods: Men aged 65-75 with any history of smoking were targeted
for screening. Medical records were reviewed electronically to exclude
patients with known aneurysms, repaired aneurysms and individuals with
an abdominal imaging study within 10 years that would have diagnosed
an AAA. Best Practice Alerts (BPA) were created in the EMR so when an
appropriate patient is seen, ofﬁce staff and providers are prompted to order
an abdominal ultrasound. AAA was deﬁned as aortic diameter 3 cm or
greater and ultrasound reports contained a standard template providing
guidance for management when an aneurysm was identiﬁed. Newly identi-
ﬁed AAA were triaged for Vascular Surgery consultation or follow-up. The
number of screening exams and AAA identiﬁed were tabulated by our
Screening and Safety Net Program.
Results: In a population of 3.6 Million, 64,848 patients met
screening criteria and 54.7% were excluded from the BPA. In the ﬁrst 8
months after starting the BPA, 12,614 abdominal ultrasound or CT scans
were performed and 1335 new AAA diagnosed. Screening rates have
increased at all medical centers and the percentage of unscreened patients
has been reduced from 45.3% to 25.9% system wide.
Conclusion: In an integrated Health Care System using an EMR,
AAA screening can be implemented with a dramatic increase in screening
exams and yield of previously undiagnosed AAA. Further analysis is required
to assess the impact of the screening program on AAA rupture rate and cost-
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Objectives: An AAA screening program implemented in 2007,
remains active today. During screening, many patients with aortic diameters
